Table 2.
Prevalence rates of CMV infection according to the type of hematological disease.
| Hematological diseases | N | CMV-positive N (%) | CMV-negative N (%) | OR (95% CI) | p -Value |
|---|---|---|---|---|---|
| Anemia (aplastic, sickle cell, hemolytic, and others) |
90 | 84 (93.3) | 6 (6.7) | 1.45 (0.57–3.72) | 0.565 |
| Platelet diseases | 39 | 37 (94.9) | 2 (5.1) | 1.86 (0.42–8.18) | 0.592 |
| Spherocytosis | 2 | 2 (100) | |||
| Hemophilia | 9 | 9 (100) | |||
| Hemoglobinopathies | 3 | 3 (100) | |||
| Leukemia | 144 | 133 (92.4) | 11 (7.6) | 1.03 (0.42–2.36) | 0.934 |
| AML | 24 | 23 (95.8) | 1 (4.2) | ||
| CML | 14 | 13 (93) | 1 (7) | ||
| ALL | 100 | 91 (91) | 9 (9) | ||
| CLL | 3 | 3 (100) | |||
| ATL | 3 | 3 (100) | |||
| Lymphoma | 24 | 22 (91.7) | 2 (8,3) | 1.04 (0.23–4.70) | 0.751 |
| Multiple myeloma | 4 | 3 (75) | 1 (25) | ||
| Polycythemia | 1 | 1 (100) | |||
| Myelodysplastic syndrome | 3 | 3 (100) | |||
| Thalassemia | 4 | 3 (75) | 1 (25) |
AML, acute myeloid leukemia; CML, chronic myeloid leukemia; ALL, acute lymphocytic leukemia; CLL, chronic lymphocytic leukemia; ATL, adult T-cell leukemia/lymphoma; OR, odds ratio; CI, confidence interval.